Literature DB >> 11986279

Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals.

María Beatríz Isa1, Laura Martínez, Miguel Giordano, Carlos Passeggi, María Cristina de Wolff, Silvia Nates.   

Abstract

A total of 258 human sera positive for measles antibodies were divided into four different groups: group 1 contained 54 sera from children after natural measles infection (immunoglobulin M [IgM] positive, early infection phase), group 2 contained 28 sera from children after measles vaccination (IgM positive, early infection phase), group 3 contained 100 sera from healthy adults (natural long-lasting immunity), and group 4 contained 76 sera from healthy children (postvaccinal long-lasting immunity). In the early phase of infection, the percent distributions of measles virus-specific IgG isotypes were similar between natural and postvaccinal immune responses. IgG1 and IgG4 were the dominant isotypes, with mean levels of detection of 100% (natural infection) and 100% (postvaccinal) for IgG1 and 96% (natural infection) and 92% (postvaccinal) for IgG4. In comparison, the IgG4 geometric mean titer (GMT) in the early phase of natural infection was significantly higher than the IgG4 GMT detected in the postvaccinal immune response (80 versus 13; 95% confidence interval). In the memory phase, IgG2 and IgG3 responses decreased significantly in both natural infection and postvaccinal groups, while IgG1 levels were maintained. In contrast, the IgG4 postvaccinal immune response decreased strongly in the memory phase, whereas IgG4 natural long-lasting immunity remained unchanged (9 versus 86%; P < 0.05). The results obtained suggest that IgG4 isotype could be used in the early phase of infection as a quantitative marker and in long-lasting immunity as a qualitative marker to differentiate between natural and postvaccinal immune responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986279      PMCID: PMC119984          DOI: 10.1128/cdli.9.3.693-697.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  24 in total

1.  Comparison of immunofluorescence and enzyme immunoassay for detection of measles-specific immunoglobulin M antibody.

Authors:  E Rossier; H Miller; B McCulloch; L Sullivan; K Ward
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

2.  Immunoglobulin subclass antibodies to varicella-zoster virus.

Authors:  Y Asano; Y Hiroishi; N Itakura; S Hirose; Y Kajita; T Nagai; T Yazaki; M Takahashi
Journal:  Pediatrics       Date:  1987-12       Impact factor: 7.124

3.  In vitro production of IgG4 by peripheral blood mononuclear cells (PBMC): the contribution of committed B cells.

Authors:  B A de Boer; Y C Kruize; M Yazdanbakhsh
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

4.  The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection.

Authors:  H Gregorek; K Madaliński; M Woynarowski; J Mikołajewicz; M Syczewska; J Socha
Journal:  Vaccine       Date:  2000-01-18       Impact factor: 3.641

Review 5.  Principles of measles control.

Authors:  F T Cutts; R H Henderson; C J Clements; R T Chen; P A Patriarca
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

6.  Virus-specific immunoglobulin G subclasses in herpes simplex and varicella-zoster virus infections.

Authors:  V A Sundqvist; A Linde; B Wahren
Journal:  J Clin Microbiol       Date:  1984-07       Impact factor: 5.948

7.  Measles virus-specific immunoglobulin G isotype immune response in early and late infections.

Authors:  M B Isa; L Martínez; M Giordano; M Zapata; C Passeggi; M C De Wolff; S Nates
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

8.  Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus.

Authors:  D D Erdman; L J Anderson; D R Adams; J A Stewart; L E Markowitz; W J Bellini
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

9.  The serum IgG subclass levels in healthy infants of 13--62 weeks of age.

Authors:  B J Zegers; M van der Giessen; E E Reerink-Brongers; J W Stoop
Journal:  Clin Chim Acta       Date:  1980-02-28       Impact factor: 3.786

10.  Subclass distribution of rubella virus-specific immunoglobulin G.

Authors:  G A Linde
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

View more
  8 in total

1.  Immunoglobulin G subclass profile of antimeasles response in vaccinated children and in adults with measles history.

Authors:  Anna P Toptygina; Alexander L Pukhalsky; Vladimir A Alioshkin
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

Review 2.  Tissue-based class control: the other side of tolerance.

Authors:  Polly Matzinger; Tirumalai Kamala
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

3.  Measles Virus Infection Among Vaccinated and Unvaccinated Children in Nigeria.

Authors:  Adedayo O Faneye; Johnson A Adeniji; Babatunde A Olusola; Babatunde O Motayo; Grace B Akintunde
Journal:  Viral Immunol       Date:  2015-06-23       Impact factor: 2.257

Review 4.  Emerging diseases: measles.

Authors:  Martin O Ota; William J Moss; Diane E Griffin
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

5.  Immunogenicity after outbreak response immunization activities among young healthcare workers with secondary vaccine failure during the measles epidemic in Korea, 2019.

Authors:  Hyeri Seok; Erica Españo; Jooyun Kim; Ji Hoon Jeon; Won Suk Choi; Yun-Kyung Kim; Jeong-Ki Kim; Dae Won Park
Journal:  BMC Infect Dis       Date:  2022-06-08       Impact factor: 3.667

Review 6.  Role of the humoral immune response during COVID-19: guilty or not guilty?

Authors:  Melyssa Yaugel-Novoa; Thomas Bourlet; Stéphane Paul
Journal:  Mucosal Immunol       Date:  2022-10-04       Impact factor: 8.701

7.  CD16 expression on monocytes in healthy individuals but not schistosome-infected patients is positively associated with levels of parasite-specific IgG and IgG1.

Authors:  Laura J Appleby; Norman Nausch; Louise Erskine; Claire D Bourke; Nadine Rujeni; Nicholas Midzi; Takafira Mduluza; Francisca Mutapi
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07

8.  Evolution of anti-SARS-CoV-2 immune response in a cohort of French healthcare workers followed for 7 months.

Authors:  B Pilmis; I Elkaibi; G Péan de Ponfilly; H Daikha; A Bouzid; A Guihot; N Castreau; P Pradere; H Ketatni; A Mondragon; G Hayem; J Le Pavec; S Laplanche; A Le Monnier
Journal:  Infect Dis Now       Date:  2022-01-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.